NI-1801

· Light Chain Bioscience / Novimmune SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NI-1801, covering 2024-10-29 to 2024-10-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers [Phase 1]